Insights

Posts about:

H2020

Spinverse helped AICCELERATE get 10 M€ funding

The European Commission recently funded AICCELERATE, a multiparty project aiming to develop AI solutions to improve patient care and hospital processes. The goal of the “AI ACCELERATOR – a Smart Hospital Care Pathway Engine” project is to demonstrate the scalability of the AI solutions for different types of healthcare use cases. The project consortium led by Helsinki University Hospital (HUS) consists of 16 partners from eight European countries.

Read More

More than just money (Part 1): Benefits of EU funding and collaboration

There is a multitude of opportunities in EU funding instruments for sustainable industries who are ready to reinvent and renew their business practices. Applying for EU funding is a long and competitive process but doing your homework will increase your company’s chances to succeed and reap the benefits of European collaboration for years to come. In this first part, we collected some key messages from a recent Business Finland webinar on European Union funding and collaboration. 

Read More
ENF2017_logo_web-red-1440x306

EuroNanoForum 2017 a look into the future: what will nanotechnology industry look like in 10 years?

EuroNanoForum 2017 event concluded on 23rd of June in Valletta, Malta after three successful conference and exhibition days that attracted participants from over 40 countries and brought nanotechnology and open innovations in focus to strengthen the competitiveness of European manufacturing industries. In addition to being a co-organiser of the event, Spinverse took an active participant role as well, with Managing Director Laura Koponen, headlining a plenary session on "nanotechnologies for industrial success".

Read More
Spinverse_reference_IP4Plasma-1-1440x700

The results of the IP4Plasma project: plasma technology innovations for medical products

The EU project IP4Plasma reached its finish line in the beginning of 2017 after three years of research and development. In the project, plasma equipment manufacturers and end-users worked with leading experts in research and technology innovation to bring cutting-edge IPR-protected innovations from the laboratory scale to industrial implementation for advanced surface treatment of materials. The project results are remarkable and include an advanced tuberculosis test, the development of a HIV detection test. new types of wound dressings with antibacterial properties and an improved sealing method for medical packaging.

Read More
background-benefits-2880x1120

Horizon 2020 - First results

On 6 July, EC published the first results of Horizon 2020 including the statistics of the first 100 calls that closed by 1 December 2014. 36 732 proposals were evaluated by 9 325 experts and about 3 200 projects have been awarded a total of €5.5 billion in EU funding. The overall success rate was about 14% (down from 20% for the whole FP7). France and Belgium had the highest success rates (about 17%). 38% of successful applicants were newcomers, which is a great improvement compared to 13% in the last year of FP7. 40% of newcomers were SMEs and this helped to meet the target of 20% for SME participation (up from 16% in FP7). The SME Instrument introduced in H2020 turned out to be very popular and 5% of the 20% EU financial contribution to SMEs ended up coming from SME Instrument. The popularity - 4 694 new applications  - caused the success rate of SME Instrument to plummet down to 7.3%.

Read More

EuroNanoForum 2015 putting research and industry frontrunners in the spotlight in Latvia 10-12 of June 2015

EuroNanoForum 2015 takes place on 10-12th June 2015 in Riga, Latvia, under the auspices of the Latvian presidency of the European Union. It is organised by the University of Latvia and Spinverse in cooperation with the European Commission’s Directorate-General for Research and Innovation and has received funding from the European Union’s Horizon 2020 research and innovation programme.

Read More